Comparative analysis of mortality and cardiometabolic outcomes in obese patients with type 2 diabetes treated with Semaglutide versus Tirzepatide: Insights from the TriNetX database

Authors

Gloria Amoako
Ekow Essien, Advocate Health - MidwestFollow
Abena Agyekum
Godslove Bonnah
Aba Kwakomah Dapaah
Elgiva Esther Yaborley Abbey

Recommended Citation

Amoako G, Essien E, Agyekum A, Bonnah G, Dapaah AK, Abbey EEY. Comparative Analysis of Mortality and Cardiometabolic Outcomes in Obese Patients with Type 2 Diabetes Treated with Semaglutide versus Tirzepatide: Insights from the TriNetX Database. American Heart Journal. 2025;290:30. doi:10.1016/j.ahj.2025.07.066

Type

Abstract